Greenstone LLC, a wholly owned subsidiary of Pfizer, Inc., recently announced a recall of two drugs due to labeling errors. The voluntary recall involves Citalopram 10mg Tablets (100-count bottle) used to treat depression, and Finasteride 5mg Tablets (90-count bottle) used to treat enlarged prostates.
A third-party manufacturing company placed the wrong labels on the bottles. Bottles labeled as Citalopram Lot # FI0510058-A may contain Finasteride. According to the press release posted on Pfizer’s website, “Women who are, or may become pregnant, should not take or handle Finasteride due to the possible risk of side effects which may cause abnormalities to the external genitalia of a developing male fetus.” Additional side effects or symptoms may occur in patients who stop taking the correct medication by inadvertently taking the mislabeled product.
For more information about the recall of Citalopram and Finasteride, you can view the Pfizer, Inc. press release here.
If you have been harmed by taking mislabeled drugs, contact defective product lawyers to discuss your legal rights. Call 1-888-BURNETTI.